The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

CEO

Country

ISIN

US00768Y2972

Listings

0 Comments

Share your thoughts

FAQ

What is AdvisorShares Psychedelics stock price today?▼

The current price of PSIL is $17.17 USD — it has increased by +2.88% in the past 24 hours. Watch AdvisorShares Psychedelics stock price performance more closely on the chart.

What is AdvisorShares Psychedelics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange AdvisorShares Psychedelics stocks are traded under the ticker PSIL.

Is AdvisorShares Psychedelics stock price growing?▼

PSIL stock has fallen by -1.66% compared to the previous week, the month change is a -0.17% fall, over the last year AdvisorShares Psychedelics has showed a +28.04% increase.

Does AdvisorShares Psychedelics pay dividends?▼

Yes, PSIL dividends are paid quarterly. The last dividend per share was 1.68 USD. As of today, Dividend Yield (FWD)% is 10.95%.

When did AdvisorShares Psychedelics complete a stock split?▼

The last stock split for AdvisorShares Psychedelics was on September 10, 2024 with a ratio of 1:10.